UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT



     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported):  March 1, 2004


                           CHINDEX INTERNATIONAL, INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


                                    DELAWARE
--------------------------------------------------------------------------------
                 (State or other jurisdiction of incorporation)


               0-24624                                  13-3097642
     ----------------------------          -------------------------------------
       (Commission File Number)              (IRS Employer Identification No.)


                 7201 WISCONSIN AVENUE, BETHESDA, MARYLAND 20814
--------------------------------------------------------------------------------
                    (Address of principal executive offices)


       Registrant's telephone number, including area code: (301) 215-7777


                                       NA
--------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)


<PAGE>


ITEM 12.  OTHER EVENTS AND REGULATION FD DISCLOSURE

THE COMPANY  CORRECTS  PRIOR  FILINGS  FOR  MATHEMATICAL  ERRORS;  NO CHANGES TO
FINANCIAL CONDITION, REVENUES, CASH FLOWS OR NET INCOME

The Company today  corrected  mathematical  errors by amending its Form 10-K for
the year ended December 31, 2002 and subsequent  Forms 10-Q. The  corrections do
not constitute changes in its financial condition,  revenues,  cash flows or net
income for the periods  affected nor in its accounting  policies.  The principal
corrections relate to an inadvertent failure to give effect to the Company's ten
percent stock dividend effected in July 2002 in calculating  subsequent weighted
average shares outstanding and corresponding per share amounts. Of the remaining
corrections, no amount changed by more than 1%, except as set forth below.

Form 10-K for the fiscal year ended December 31, 2002:

     o    In   "Managements   Discussion  and  Analysis  of  Financial
          Condition and Results of Operations" ("MD&A"),  the increase
          in costs  other than  salaries  in the  healthcare  services
          segment  from fiscal 2000 to fiscal 2001 has been  corrected
          from $996,000 to $779,000,  which change does not affect any
          line item in the presented financial statements.

     o    In "Selected  Financial  Data," the percent  increase in net
          sales in fiscal  2000 over  fiscal  1999 has been  corrected
          from 18% to 21%,  which change does not affect any line item
          in the presented  financial  statements  (including such net
          sales amounts, which were correct as so presented).

Form 10-Q for the period ended March 31, 2003:

     o    In  MD&A,  the  increase  in  development  expenses  in  the
          healthcare   services   segment  related  to  the  Company's
          Shanghai  hospital  between the quarters  presented has been
          corrected  from $176,000 to $186,000,  which change does not
          affect any line item in the presented financial statements.

     o    In MD&A,  the  benefit  from  income  taxes for the  earlier
          quarter has been corrected from $109,000 to $113,000,  which
          change  does  not  affect  any  line  item in the  presented
          financial statements.

Form 10-Q for the quarter ended December 31, 2003:

     o    In MD&A,  the  short-term  debt on which there was  interest
          expense as of  December  31,  2003 has been  corrected  from
          $6,774,000  to  $6,499,000,  which amount was correct in the
          presented financial statements.

     o    In MD&A,  the  long-term  debt on which  there was  interest
          expense as of  December  31,  2003 has been  corrected  from
          $182,000  to  $154,000,  which  amount  was  correct  in the
          presented financial statements.

<PAGE>

     o    In MD&A,  the interest  expense for the earlier  quarter has
          been  corrected  from  $40,000 to $27,000,  which amount was
          correct in the presented financial statements.

     o    In  MD&A,   the  borrowings   under  the  Company's   credit
          facilities as of December 31, 2003 has been  corrected  from
          $1,267,000 to  $1,291,000,  which change does not affect any
          line item in the presented financial statements.

     o    In MD&A,  the tax benefit  for the earlier  quarter has been
          corrected  from $152,000 to $150,000,  which change also has
          been made in the presented financial statements.

     o    In MD&A, the bank loans comprising  short-term loan payables
          as of December 31, 2003 has been corrected  from  $2,841,000
          to $2,873,000, which change does not affect any line item in
          the presented financial statements.


                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                        CHINDEX INTERNATIONAL, INC.
                                        (Registrant)


       MARCH 1, 2004                    By: /s/ LAWRENCE PEMBLE
     -----------------                     ------------------------------------
           Date                             Lawrence Pemble
                                            Chief Financial Officer